Claim OwnershipOpylPod
Subscribed: 0Played: 0
Subscribe
© Copyright Opyl Limited, 2023. All rights reserved.
Description
A new podcast discussing emerging technologies being developed to improve clinical trials, particularly solutions that the Opyl team is commercializing. Hosted by Opyl CEO, Michelle Gallaher, Opyl team members are featured talking about Opyl tech as well as several external experts in the clinical trial and artificial intelligence fields. Recommended for Opyl customers and shareholders to gain a deeper dive into Opyl technologies and the use case in the global drug and devices development industry.
5 Episodes
Reverse
Welcome to another OpylPod, the last in our series celebrating International Clinical Trials Day.
Opyl CEO Michelle Gallaher recently spoke to James Stewart, Head of Commercial at Pancare, who provide vital support for Aussies impacted by upper gastrointestinal cancers. They discuss the evolving role of Advocacy Groups in patient communities and the importance of connecting health research.
Enjoy!
Welcome to another OpylPd, continuing our series in celebration of International Clinical Trials Day last Saturday.
Opyl CEO Michelle Gallaher recently spoke to Dr Rebecca Saunderson, founder and CEO of Consentic - a start-up making waves with new technologies that streamline consent in health research. They discuss all things process, intelligent technology and the evolving participant experience in clinical studies.
Enjoy!
Welcome to another OpylPod, this week as part of a series of discussions in recognition of International Clinical Trial Day this coming Saturday.
Michelle Gallaher, founder of health research participant platform Opin.AI, speaks with Dr Megan Robertson, Group Chief Research Officer with St Vincent's Health Australia and Director of the St Vincent's Research Valet Service. They discuss the focuses of clinical sites and risks faced by study participants in a post-pandemic world.
Enjoy!
Welcome to another OpylPod, this week as part of a series of discussions in recognition of International Clinical Trial Day this coming Saturday.
Michelle Gallaher, CEO of Opyl and founder of Opin.AI speaks to Sharon Charles, Vice President of Clinical Operations at international CRO ProPharma Group, about the impact of the COVID-19 pandemic on health research.
Enjoy!
Join us as we delve into the world of TrialKey, a cutting-edge technology developed by Opin, with its CEO Michelle Gallaher and Head of Technology Damon Rasheed. Discover how this solution is predicting the success of clinical trials with machine learning and advanced AI, and the impact it is having on the drug development industry. Tune in to learn how you can stay ahead of the curve.
Comments
Download from Google Play
Download from App Store
United States